Summary: Vanda Pharmaceuticals reported its second-quarter 2024 financial and operational results, emphasizing efforts to expand the use of Hetlioz (tasimelteon) for pediatric insomnia and jet lag disorder. The company notes its financial performance was impacted by generic … [Read more...]
Video Analysis Sleep Monitoring Solution Gets Regulatory Nods
Summary: Oxehealth has received FDA 510(k) clearance and CE Mark approval for its new software, Oxevision Sleep. This noncontact sleep monitoring device uses video analysis to assess patient movement, activity, and physiological signs in inpatient settings without attaching … [Read more...]